BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26194915)

  • 1. Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.
    McAllister KA; Mar AC; Theobald DE; Saksida LM; Bussey TJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3883-97. PubMed ID: 26194915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.
    Janhunen SK; Svärd H; Talpos J; Kumar G; Steckler T; Plath N; Lerdrup L; Ruby T; Haman M; Wyler R; Ballard TM
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4059-83. PubMed ID: 26070547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.
    McLean SL; Harte MK; Neill JC; Young AM
    J Psychopharmacol; 2017 Jun; 31(6):660-666. PubMed ID: 28441905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia.
    Pyndt Jørgensen B; Krych L; Pedersen TB; Plath N; Redrobe JP; Hansen AK; Nielsen DS; Pedersen CS; Larsen C; Sørensen DB
    Physiol Behav; 2015 Mar; 141():32-9. PubMed ID: 25545766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal GABA
    Neugebauer NM; Miyauchi M; Sato T; Tadano J; Akal H; Ardehali H; Meltzer HY
    Behav Brain Res; 2018 Apr; 342():11-18. PubMed ID: 29289597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
    Abdul-Monim Z; Neill JC; Reynolds GP
    J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A; Santana N; Artigas F
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats.
    Schwabe K; Klein S; Koch M
    Behav Brain Res; 2006 Mar; 168(1):150-60. PubMed ID: 16387372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia.
    Gigg J; McEwan F; Smausz R; Neill J; Harte MK
    J Psychopharmacol; 2020 Jan; 34(1):115-124. PubMed ID: 31580184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats.
    Loureiro CM; Fachim HA; Harte MK; Dalton CF; Reynolds GP
    J Psychopharmacol; 2022 Feb; 36(2):238-244. PubMed ID: 35102781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handling prevents and reverses cognitive deficits induced by sub-chronic phencyclidine in a model for schizophrenia in rats.
    Landreth K; Burgess M; Watson L; Lorusso JM; Grayson B; Harte MK; Neill JC
    Physiol Behav; 2023 May; 263():114117. PubMed ID: 36781093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S7-15. PubMed ID: 26387382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions.
    Tait DS; Marston HM; Shahid M; Brown VJ
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):295-306. PubMed ID: 18925388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.
    McKibben CE; Jenkins TA; Adams HN; Harte MK; Reynolds GP
    Behav Brain Res; 2010 Mar; 208(1):132-6. PubMed ID: 19914297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism.
    Horiguchi M; Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
    Behav Brain Res; 2016 Mar; 301():132-41. PubMed ID: 26342283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA
    Rajagopal L; Huang M; Michael E; Kwon S; Meltzer HY
    Neuropsychopharmacology; 2018 Nov; 43(12):2468-2477. PubMed ID: 30093697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDA receptor immunodensity in the prefrontal cortex and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wetchateng T; Sireeratawong S
    J Med Assoc Thai; 2013 Feb; 96(2):231-8. PubMed ID: 23936991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.
    Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY
    Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDAR1 immunodensity in the prefrontal cortex, striatum and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S50-5. PubMed ID: 25518293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.